Serum Uric Acid Level and Its Association with Metabolic Syndrome and Carotid Atherosclerosis in Patients with Type 2 Diabetes.

Qin Li,Zhen Yang,Bin Lu,Jie Wen,Zi Ye,Lili Chen,Min He,Xiaoming Tao,Weiwei Zhang,Ying Huang,Zhaoyun Zhang,Shen Qu,Renming Hu
DOI: https://doi.org/10.1186/1475-2840-10-72
IF: 8.949
2011-01-01
Cardiovascular Diabetology
Abstract:OBJECTIVE:We aimed to investigate whether elevated serum uric acid concentrations are associated with higher risk of metabolic syndrome (MetS) and carotid atherosclerosis in patients with type 2 diabetes.METHODS:We conducted a population-based cross-sectional survey in Shanghai, with a total of 395 men and 631 women age 41 to 92 years. The carotid artery intima-media thickness (IMT) and carotid atherosclerotic plaques (PLQ) were measured by B-mode ultrasound. MetS was defined according to the updated National Cholesterol Education Program Adult Treatment Panel III criteria for Asian Americans.RESULTS:Uric acid levels were negatively associated with duration of diabetes, fasting plasma glucose, glycohemoglobin, eGFR, HDL-cholesterol (all P < 0.001) and positively with BMI, CRP, waist circumference, triglycerides, systolic blood pressure, ACR, HOMA-IR and IMT (all P < 0.05). In the highest quartile of uric acid levels, the risks were substantially higher for MetS [odds ratio 3.97, (95% confidence interval 2.58-6.13)] (P < 0.001 for trend) and PLQ [odds ratio 2.71 (95% confidence interval 1.62-4.47)] (p = 0.013 for trend) compared with that in the lowest quartile of uric acid levels after multiple adjustment. These associations remained significant after further adjustment for potential confounders.CONCLUSIONS:Serum uric acid level is associated with MetS and is an independent risk factor for carotid atherosclerosis in patients with type 2 diabetes.
What problem does this paper attempt to address?